134 related articles for article (PubMed ID: 2510097)
1. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat.
Dugovic C; Leysen JE; Wauquier A
Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097
[TBL] [Abstract][Full Text] [Related]
2. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.
Dugovic C; Wauquier A; Leysen JE; Marrannes R; Janssen PA
Psychopharmacology (Berl); 1989; 97(4):436-42. PubMed ID: 2524856
[TBL] [Abstract][Full Text] [Related]
3. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
Dugovic C; Leysen JE; Janssen PF; Wauquier A
Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
[TBL] [Abstract][Full Text] [Related]
4. Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment.
Dugovic C; Meert TF; Ashton D; Clincke GH
Psychopharmacology (Berl); 1992; 108(3):263-70. PubMed ID: 1523277
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
Dugovic C; Wauquier A; Janssen PA
Neuropharmacology; 1989 Dec; 28(12):1431-3. PubMed ID: 2482460
[TBL] [Abstract][Full Text] [Related]
6. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
Bjorvatn B; Ursin R
Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
[TBL] [Abstract][Full Text] [Related]
7. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
Silhol S; Glin L; Gottesmann C
Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT2 antagonist ritanserin decreases sleep in cats.
Sommerfelt L; Ursin R
Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
[TBL] [Abstract][Full Text] [Related]
9. Serotonin excitation of facial motoneurons: receptor subtype characterization.
Rasmussen K; Aghajanian GK
Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
[TBL] [Abstract][Full Text] [Related]
10. Power spectral electroencephalogram analysis of the effects of ritanserin in freely moving rats during quiet waking.
Moyanova S; Kirov R; Ivanova V
Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):605-11. PubMed ID: 9500124
[TBL] [Abstract][Full Text] [Related]
11. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat.
Dugovic C; Wauquier A
Eur J Pharmacol; 1987 May; 137(1):145-6. PubMed ID: 2956115
[No Abstract] [Full Text] [Related]
12. 5-Hydroxytryptamine (serotonin) enhances ventricular arrhythmias induced by acute coronary artery ligation in rats.
el-Mahdy SA
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):383-6. PubMed ID: 2117299
[TBL] [Abstract][Full Text] [Related]
13. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
Kleinlogel H; Burki HR
Neuropsychobiology; 1987; 17(4):206-12. PubMed ID: 2964564
[TBL] [Abstract][Full Text] [Related]
14. Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis.
Raghavendra V; Kulkarni SK
Brain Res; 2000 Mar; 860(1-2):112-8. PubMed ID: 10727629
[TBL] [Abstract][Full Text] [Related]
15. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
17. Age-related effect of ritanserin on the sleep-waking phases in rats.
Kirov R; Moyanova S
Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
[TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
19. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
[TBL] [Abstract][Full Text] [Related]
20. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
